NCT06715085 - PRGF-ENDORET® Infiltrations in the Treatment of Low Back Pain. | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 23, 2025

Primary Completion Date

February 1, 2026

Study Completion Date

February 1, 2027

Conditions

Diseases [C] - Musculoskeletal Diseases [C05

Interventions

DRUG

Plasma Rich in Growth Factors (PRGF)

The PRGF application consists of three series of infiltrations in the intervertebral disc, epidural space and facets, with a frequency of two weeks.

DRUG

Corticosteroid solution (Celestone Cronodose suspension for injection) in saline solution.

The corticosteroid solution application consists of two series of infiltrations of solution of corticosteroid (Celestone Cronodose injectable suspension \[betamethasone\]) and saline solution in the epidural space and in the facets, with a periodicity of one month between them.

Trial Locations (1)

01005

RECRUITING

Clínica Eduardo Anitua, Vitoria-Gasteiz